IL-20拮抗剂用于治疗肝脏疾病

用IL-20拮抗剂减轻患有或怀疑患有肝脏疾病的对象的肝纤维化，该拮抗剂可以是阻断由IL-20介导的信号转导途径的抗体。这些抗体包括特异性阻断IL-20信号转导途径的抗IL-20抗体和抗IL-20R抗体。 Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such a...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 17.08.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:用IL-20拮抗剂减轻患有或怀疑患有肝脏疾病的对象的肝纤维化，该拮抗剂可以是阻断由IL-20介导的信号转导途径的抗体。这些抗体包括特异性阻断IL-20信号转导途径的抗IL-20抗体和抗IL-20R抗体。 Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
Bibliography:Application Number: CN201380051640